$ENOB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Enochian Biosciences Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Enochian Biosciences Inc. Get notifications about new insider transactions in Enochian Biosciences Inc for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 25 2021 | ENOB | Enochian Bioscienc ... | McNicol Jayne | Director | Option Exercise | A | 5.78 | 26,498 | 153,158 | 26,498 | |
| Mar 11 2021 | ENOB | Enochian Bioscienc ... | D An Evelyn | Director | Option Exercise | A | 3.77 | 19,894 | 75,000 | 19,894 | |
| Mar 11 2021 | ENOB | Enochian Bioscienc ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 3.77 | 19,894 | 75,000 | 19,894 | |
| Dec 16 2020 | ENOB | Enochian Bioscienc ... | Dybul Mark | Executive Vice Chai ... | Buy | J | 0.00 | 180 | 0 | 66,196 | 66 K to 66.2 K (+0.27 %) |
| Dec 16 2020 | ENOB | Enochian Bioscienc ... | Sandler Carl Forest Jr | Director | Buy | J | 0.00 | 61,249 | 0 | 4,961,363 | 4.9 M to 5 M (+1.25 %) |
| Jun 19 2020 | ENOB | Enochian Bioscienc ... | Dybul Mark | Executive Vice Chai ... | Option Exercise | A | 8.00 | 450,000 | 3,600,000 | 450,000 | |
| Jan 09 2020 | ENOB | Enochian Bioscienc ... | Puche Luisa | Chief Financial Off ... | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
| Jan 09 2020 | ENOB | Enochian Bioscienc ... | Puche Luisa | Chief Financial Off ... | Buy | M | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Aug 26 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | A | 4.90 | 3,346 | 16,395 | 3,346 | |
| Aug 26 2019 | ENOB | Enochian Bioscienc ... | Sandler Carl Forest Jr | Director | Option Exercise | A | 7.10 | 8,248 | 58,561 | 8,248 | |
| Aug 26 2019 | ENOB | Enochian Bioscienc ... | Gronfeldt-Sorensen Henrik | Director | Option Exercise | A | 5.80 | 7,759 | 45,002 | 7,759 | |
| Aug 26 2019 | ENOB | Enochian Bioscienc ... | D An Evelyn | Director | Option Exercise | A | 6.25 | 9,173 | 57,331 | 9,173 | |
| Aug 26 2019 | ENOB | Enochian Bioscienc ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 6.25 | 9,173 | 57,331 | 9,173 | |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Sandler Carl Forest Jr | Director | Buy | J | 0.00 | 3,631,234 | 0 | 22,445,397 | 18.8 M to 22.4 M (+19.30 %) |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Dybul Mark | Executive Vice Chai ... | Buy | J | 0.00 | 10,680 | 0 | 66,016 | 55.3 K to 66 K (+19.30 %) |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Sandler Carl Forest Jr | Director | Buy | J | 0.00 | 3,631,234 | 0 | 22,445,397 | 18.8 M to 22.4 M (+19.30 %) |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | X | 1.30 | 3,092,307 | 4,019,999 | 0 | |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Dybul Mark | Executive Vice Chai ... | Buy | J | 0.00 | 10,680 | 0 | 66,016 | 55.3 K to 66 K (+19.30 %) |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | X | 1.30 | 3,092,307 | 4,019,999 | 9,668,351 | 6.6 M to 9.7 M (+47.02 %) |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | X | 1.30 | 3,092,307 | 4,019,999 | 0 | |
| Aug 01 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | X | 1.30 | 3,092,307 | 4,019,999 | 9,668,351 | 6.6 M to 9.7 M (+47.02 %) |
| Jun 21 2019 | ENOB | Enochian Bioscienc ... | Puche Luisa | Chief Financial Off ... | Option Exercise | A | 6.15 | 15,000 | 92,250 | 15,000 | |
| Jun 21 2019 | ENOB | Enochian Bioscienc ... | Puche Luisa | Chief Financial Off ... | Option Exercise | A | 6.15 | 60,000 | 369,000 | 60,000 | |
| Jun 06 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 6.70 | 31,500 | 211,050 | 6,576,044 | 6.5 M to 6.6 M (+0.48 %) |
| Jun 05 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 6.70 | 40,000 | 268,000 | 6,544,544 | 6.5 M to 6.5 M (+0.61 %) |
| Jun 05 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 6.60 | 20,000 | 132,000 | 6,504,544 | 6.5 M to 6.5 M (+0.31 %) |
| Jun 05 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 6.25 | 5,014 | 31,338 | 6,448,344 | 6.4 M to 6.4 M (+0.08 %) |
| May 30 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 6.61 | 36,200 | 239,282 | 6,479,530 | 6.4 M to 6.5 M (+0.56 %) |
| May 24 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 5.76 | 500 | 2,880 | 6,443,330 | 6.4 M to 6.4 M (+0.01 %) |
| May 24 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 5.76 | 500 | 2,880 | 6,443,330 | 6.4 M to 6.4 M (+0.01 %) |
| May 23 2019 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 5.75 | 20,000 | 115,000 | 6,442,830 | 6.4 M to 6.4 M (+0.31 %) |
| Jan 11 2019 | ENOB | Enochian Bioscienc ... | Gronfeldt-Sorensen Henrik | Director | Option Exercise | X | 2.00 | 50,000 | 100,000 | 0 | |
| Jan 11 2019 | ENOB | Enochian Bioscienc ... | Gronfeldt-Sorensen Henrik | Director | Buy | P | 2.00 | 50,000 | 100,000 | 50,000 | 0 to 50 K |
| Jan 03 2019 | ENOB | Enochian Bioscienc ... | Dybul Mark | Executive Vice Chai ... | Buy | J | 0.00 | 3,732 | 0 | 55,336 | 51.6 K to 55.3 K (+7.23 %) |
| Jan 03 2019 | ENOB | Enochian Bioscienc ... | Sandler Carl Forest Jr | Director | Buy | J | 0.00 | 1,268,880 | 0 | 18,814,163 | 17.5 M to 18.8 M (+7.23 %) |
| Dec 28 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | X | 1.30 | 1,307,693 | 1,700,001 | 3,092,307 | |
| Dec 28 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | X | 1.30 | 1,307,693 | 1,700,001 | 6,422,830 | 5.1 M to 6.4 M (+25.57 %) |
| Dec 28 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 8.00 | 92,968 | 743,744 | 5,115,137 | 5 M to 5.1 M (+1.85 %) |
| Dec 07 2018 | ENOB | Enochian Bioscienc ... | Dybul Mark | Director | Option Exercise | A | 6.50 | 300,000 | 1,950,000 | 312,834 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | P | 2.00 | 250,000 | 500,000 | 250,000 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | X | 2.00 | 250,000 | 500,000 | 0 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | X | 1.30 | 1,000,000 | 1,300,000 | 4,400,000 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | X | 2.00 | 250,000 | 500,000 | 5,020,869 | 4.8 M to 5 M (+5.24 %) |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | X | 1.30 | 1,000,000 | 1,300,000 | 4,770,869 | 3.8 M to 4.8 M (+26.52 %) |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 5.38 | 1,300 | 6,994 | 5,022,169 | 5 M to 5 M (+0.03 %) |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | A | 5.74 | 7,840 | 45,002 | 7,840 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | P | 2.00 | 250,000 | 500,000 | 250,000 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | X | 2.00 | 250,000 | 500,000 | 0 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | X | 1.30 | 1,000,000 | 1,300,000 | 4,400,000 | |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | X | 2.00 | 250,000 | 500,000 | 5,020,869 | 4.8 M to 5 M (+5.24 %) |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | X | 1.30 | 1,000,000 | 1,300,000 | 4,770,869 | 3.8 M to 4.8 M (+26.52 %) |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Buy | P | 5.38 | 1,300 | 6,994 | 5,022,169 | 5 M to 5 M (+0.03 %) |
| Nov 07 2018 | ENOB | Enochian Bioscienc ... | Sindlev Rene | Director | Option Exercise | A | 5.74 | 7,840 | 45,002 | 7,840 | |
| Sep 27 2018 | DDRT | Enochian Bioscienc ... | Dybul Mark | Director | Option Exercise | A | 5.74 | 5,226 | 29,997 | 12,834 | |
| Sep 27 2018 | DDRT | Enochian Bioscienc ... | SAPIRSTEIN JAMES | Director | Option Exercise | A | 5.74 | 5,226 | 29,997 | 12,770 | |
| Sep 27 2018 | DDRT | Enochian Bioscienc ... | D An Evelyn | Director | Option Exercise | A | 5.74 | 5,226 | 29,997 | 12,770 | |
| Jun 04 2018 | DDRT | Enochian Bioscienc ... | Leire, Eric Jean Marie | Buy | P | 5.25 | 500 | 2,625 | 73,246 | 72.7 K to 73.2 K (+0.69 %) | |
| Jun 04 2018 | DDRT | Enochian Bioscienc ... | Leire, Eric Jean Marie | Buy | P | 5.33 | 200 | 1,066 | 72,746 | 72.5 K to 72.7 K (+0.28 %) | |
| Jun 04 2018 | DDRT | Enochian Bioscienc ... | Leire, Eric Jean Marie | Buy | P | 5.25 | 300 | 1,575 | 72,546 | 72.2 K to 72.5 K (+0.42 %) | |
| Jun 04 2018 | DDRT | Enochian Bioscienc ... | Leire, Eric Jean Marie | Buy | P | 5.40 | 754 | 4,072 | 72,246 | 71.5 K to 72.2 K (+1.05 %) | |
| Jun 04 2018 | DDRT | Enochian Bioscienc ... | Leire, Eric Jean Marie | Buy | P | 5.50 | 190 | 1,045 | 71,492 | 71.3 K to 71.5 K (+0.27 %) | |
| Oct 19 2017 | DDRT | DanDrit Biotech US ... | Sindlev Rene | Director | Option Exercise | P | 2.00 | 250,000 | 500,000 | 5,650,000 | |
| Sep 22 2017 | DDRT | DanDrit Biotech US ... | Leire, Eric Jean Marie | Chief Executive Off ... | Grant | A | 1.80 | 62,687 | 112,837 | 71,302 | 8.6 K to 71.3 K (+727.65 %) |
| Sep 29 2016 | DDRT | DanDrit Biotech US ... | PETERSEN ALDO | Director | Option Exercise | A | 2.00 | 300,000 | 600,000 | 300,000 | |
| Sep 29 2016 | DDRT | DanDrit Biotech US ... | Nielsen, Niels Erik | Director | Option Exercise | A | 2.00 | 300,000 | 600,000 | 300,000 | |
| Sep 29 2016 | DDRT | DanDrit Biotech US ... | Leire, Eric Jean Marie | Chief Executive Off ... | Option Exercise | A | 2.00 | 300,000 | 600,000 | 300,000 | |
| Feb 14 2014 | DDRT | DanDrit Biotech US ... | NLBDIT 2010 SERVICES, LLC | 10% Owner | Sell | U | 0.00 | 4,400,000 | 440 | 600,000 | 5 M to 600 K (-88.00 %) |
| Feb 14 2014 | DDRT | DanDrit Biotech US ... | NLBDIT 2010 SERVICES, LLC | 10% Owner | Sell | U | 0.00 | 4,400,000 | 440 | 600,000 | 5 M to 600 K (-88.00 %) |
| Feb 14 2014 | DDRT | DanDrit Biotech US ... | NLBDIT 2010 SERVICES, LLC | 10% Owner | Sell | U | 0.00 | 4,400,000 | 440 | 600,000 | 5 M to 600 K (-88.00 %) |
Page: 1